2024 ASCRS Continuing Medical Education
CME Mission Statement
ASCRS’ continuing medical education mission is to improve the competence of ophthalmologists/anterior segment surgeons by offering an avenue for the presentation and discussion of innovative techniques and technologies and fostering an open environment where current practices are presented and questions and improvements in patient care are continually sought.
Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.
Designation Statement
The American Society of Cataract and Refractive Surgery designates the ASCRS Glaucoma Day for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
All CME activities approved for AMA PRA Category 1 Credit™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.
Physicians can claim CME credit up to the maximum listed above for attending the Physicians Program (ASCRS), including scientific films and posters on-demand, scientific papers, courses, symposia and general sessions). Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits. Note: All attendees must have their badges to be eligible to claim credits and evaluate the program.
Target Audience
Practicing ophthalmologists who care for patients with glaucoma‐related conditions.
Educational Objectives
- Effectively evaluate current and new diagnostic testing modalities to assist in the early diagnosis of the glaucoma patient and glaucoma suspect as well as disease progression
- Make treatment decisions using evidence-based recommendations regarding the use of pharmacologic and laser therapies for the treatment of glaucoma
- Evaluate best phacoemulsification treatment options and considerations for patients with complex, pre-existing, and advanced glaucoma
- Discuss recent and emerging microinvasive glaucoma surgical (MIGS) options
- Integrate pearls to improve glaucoma surgical outcomes
- Implement strategies to manage glaucoma surgical outcomes
- Give examples of how to include AI and/or Virtual Reality in glaucoma treatments
Financial Interest Index
As a provider accredited by the Accreditation council for Continuing Medical Education, ASCRS must ensure balance, independence, objectivity, and scientific rigor in all its individually or jointly provided activities.
All individuals participating in an activity designated for CME credit must disclose any financial interest or relationship with an ineligible company within the past 24 months that produces, markets, sells, resells, or distributes ophthalmic products/devices/drugs or services used on or by patients that are discussed in an educational presentation or lack thereof. Financial interest can include such things as grants or research support, consultant, stockholder, member of speaker’s bureau, et.
The intent of this disclosure is not to disqualify anyone from participating, but to provide the program committee with information so they can design and implement a balanced, independent, and scientific educational activity. The Financial Interest Index provides information to attendees, so they can make their own judgement regarding the interest or relationship and the materials presented. A complete listing of relations disclosed, and their corresponding codes are below.
Session I: ASCRS/AGS Joint Symposium
Manjool Shah, MD is a consultant for Abbvie, Alcon and Glaukos.
Nathan Radcliffe, MD is a consultant for Alcon, Allergan/Abbvie and Glaukos.
Davinder Grover, MD is a consultant for, receives lecture fees and receives research/grant support from Allergan.
Jella An, MD is a consultant for Alcon and receives lecture fees and research/grant support from Abbvie.
Aakriti Garg Shukla, MD has no relevant financial relationships.
Paul Harasymowycz, MD, FRCSC is a consultant for, receives lecture fees from and receives research/grant support from Alcon and Johnson and Johnson.
Sahar Bedrood, MD, PhD is a consultant for Abbvie/Allergan and Glaukos. Receives lecture fees from Abbvie/Allergan and Glaukos.
Michael Greenwood, MD is a consultant for Zeiss. Receives lecture fees from Alcon and Johnson and Johnson.
Session II: Glaukomtecken
Oluwatosin Smith, MD has no relevant financial relationships.
Manjool Shah, MD has no relevant financial relationships.
Michelle Butler, MD has no relevant financial relationships.
Inder Paul Singh, MD has no relevant financial relationships.
Sanjay Patel, MD is a consultant for receives lecture fees from and receives research/grant support from Alcon.
Alessandro Jammal, MD has no relevant financial relationships.
Robert Chang, MD is a consultant for Alcon and Apple. Receives research/grant support from Alcon.
Inas Aboobakar, MD has no relevant financial relationships.
Session III: Medications, Lasers, & Lifestyles
Deborah Ristvedt, DO is a consultant for Glaukos.
Arsham Sheybani, MD is a consultant for Glaukos and Elios.
Erin Sieck, MD has no relevant financial relationships.
Arthur Sit, SM, MD is a consultant for Injectsense, PolyActivia, Pty, Qlaris Bio, Inc. and Santen Pharmaceuticals Asia, Pty. Receives research/grant support from Nicox Ophthalmics and Qlaris Bio, Inc. Is an investor in Injectsense, Inc..
George Reiss, MD receives research/grant support from Glaukos.
Monica Ertel, MD, PhD has no relevant financial relationships.
Gus Gazzard, MD, PRCOphth, MA, MBBS has no relevant financial relationships.
Leonard Seibold, MD has no relevant financial relationships.
Sabrina Muktar, MD has no relevant financial relationships.
Sarah Van Tassel, MD Is a consultant for Belkin, Glaukos and Thea.
Session IV: Surgical Spotlight
David Crandall, MD is a consultant for Alcon, Bausch and Lomb and Johnson and Johnson Vision.
Shar Bedrood, MD, PhD is a consultant for and receives lecture fees from Abbvie/Allergan and Glaukos.
David Sola-Del Valle, MD has no relevant financial relationships.
Ike Ahmed, MD is a consultant for Alcon, Abbvie, Glaukos and Sight Sciences.
Roma Patel, MD, MBA is a consultant for Allergan.
Parag Parekh, MD, MPA has no relevant financial relationships.
Emily Schehlien, MD has no relevant financial relationships.
Kelly Muir, MD has no relevant financial relationships.
Michael Boland, MD has no relevant financial relationships.
Session V: Stephen A. Obstaum, MD Honored Lecture
Leon Herndon, MD has no relevant financial relationships.
Session VI: 14th Annual Video Session: Complications and a Reay of Hope
Sameh Mosaed, MD has no relevant financial relationships.
Jody Piltz-Seymour, MD has no relevant financial relationships.
Douglas Rhee, MD has no relevant financial relationships.
Nathan Radcliffe, MD has no relevant financial relationships.
Manjool Shah, MD has no relevant financial relationships.
Huda Sheheitli, MD is a consultant for Abbvie.
Sirjhun Patel, MD has no relevant financial relationships.
Victoria Ly, MD has no relevant financial relationships.
Carrie Braden, ASCRS Staff, have no financial interests.
All of the relevant financial relationships for these individuals have been mitigated.
